1. Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nature reviews Gastroenterology & hepatology. 2020 Mar;17(3):139-52. PubMed PMID: 31792430.
2. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature reviews Gastroenterology & hepatology. 2019 Oct;16(10):589-604. PubMed PMID: 31439937. Pubmed Central PMCID: 6813818.
3. Saillard C, Schmauch B, Laifa O, Moarii M, Toldo S, Zaslavskiy M, et al. Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides. Hepatology. 2020 Feb 28. PubMed PMID: 32108950.
4. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. Journal of hepatology. 2003 Feb;38(2):200-7. PubMed PMID: 12547409.
5. Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, et al. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. Journal of hepatology. 2016 Mar;64(3):601-8. PubMed PMID: 26551516.
6. Yang S, Cai H, Hu B, Tu J. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Bioence Reports. 2019;39(7).
7. Pan W, Li W, Zhao J, Huang Z, Zhao J, Chen S, et al. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Molecular oncology. 2019 Oct;13(10):2246-58. PubMed PMID: 31368655. Pubmed Central PMCID: PMC6763783. Epub 2019/08/02. eng.
8. Ding Y, Sun Z, Zhang S, Chen Y, Zhou B, Li G, et al. Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and its Clinical Significance. Journal of Cancer. 2020;11(11):3369-74. PubMed PMID: 32231743. Pubmed Central PMCID: 7097951.
9. Yan PH, Wang L, Chen H, Yu FQ, Guo L, Liu Y, et al. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways. European review for medical and pharmacological sciences. 2019 Oct;23(19):8287-94. PubMed PMID: 31646558. Epub 2019/10/28. eng.
10. Wang YG, Wang T, Shi M, Zhai B. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. Journal of experimental & clinical cancer research : CR. 2019 Apr 10;38(1):153. PubMed PMID: 30971290. Pubmed Central PMCID: PMC6458726. Epub 2019/04/12. eng.
11. Ding H, Liu J, Zou R, Cheng P, Su Y. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation. Journal of experimental & clinical cancer research : CR. 2019 May 9;38(1):189. PubMed PMID: 31072375. Pubmed Central PMCID: PMC6509822. Epub 2019/05/11. eng.
12. Liao H, Zhang J, Shestopal S, Szabo G, Castle A, Castle D. Nonredundant function of secretory carrier membrane protein isoforms in dense core vesicle exocytosis. American journal of physiology Cell physiology. 2008 Mar;294(3):C797-809. PubMed PMID: 18171723.
13. Vadakekolathu J, Al-Juboori SIK, Johnson C, Schneider A, Buczek ME, Di Biase A, et al. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell death & disease. 2018 Mar 1;9(3):344. PubMed PMID: 29497041. Pubmed Central PMCID: 5832821.
14. Biewenga P, Buist MR, Moerland PD, Ver Loren van Themaat E, van Kampen AH, ten Kate FJ, et al. Gene expression in early stage cervical cancer. Gynecologic oncology. 2008 Mar;108(3):520-6. PubMed PMID: 18191186.
15. Wang W, Lou W, Ding B, Yang B, Lu H, Kong Q, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging. 2019 May 6;11(9):2610-27. PubMed PMID: 31061236. Pubmed Central PMCID: 6535056.
16. Zong Z, Song Y, Xue Y, Ruan X, Liu X, Yang C, et al. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway. Journal of cellular and molecular medicine. 2019 Aug;23(8):5048-62. PubMed PMID: 31207033. Pubmed Central PMCID: PMC6653555. Epub 2019/06/18. eng.
17. Shao Q, Wang Q, Wang J. LncRNA SCAMP1 regulates ZEB1/JUN and autophagy to promote pediatric renal cell carcinoma under oxidative stress via miR-429. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019 Dec;120:109460. PubMed PMID: 31550675. Epub 2019/09/25. eng.
18. Song R, Liu Z, Lu L, Liu F, Zhang B. Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer. DNA and cell biology. 2020 Jun;39(6):1041-50. PubMed PMID: 32401536. Epub 2020/05/14. eng.
19. Yang S, Lee KT, Lee JY, Lee JK, Lee KH, Rhee JC. Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013 Oct;34(5):2731-9. PubMed PMID: 23653380. Epub 2013/05/09. eng.
20. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell proliferation. 2003 Jun;36(3):131-49. PubMed PMID: 12814430. Pubmed Central PMCID: 6496723.
21. Nguyen-Ba G, Vasseur P. Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncology reports. 1999 Jul-Aug;6(4):925-32. PubMed PMID: 10373683.
22. Brooks G, La Thangue NB. The cell cycle and drug discovery: the promise and the hope. Drug discovery today. 1999 Oct;4(10):455-64. PubMed PMID: 10481141.
23. Suryadinata R, Sadowski M, Sarcevic B. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates. Bioscience reports. 2010 Mar 17;30(4):243-55. PubMed PMID: 20337599.
24. Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Drug design, development and therapy. 2015;9:1627-52. PubMed PMID: 25834401. Pubmed Central PMCID: 4365748.
25. Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Dec 20;23(36):9408-21. PubMed PMID: 16361640.
26. Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene. 2003 Aug 11;22(33):5208-19. PubMed PMID: 12910258.
27. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000 Nov 16;408(6810):307-10. PubMed PMID: 11099028.
28. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998 Aug 28;281(5381):1312-6. PubMed PMID: 9721091. Epub 1998/08/28. eng.
29. Yu C, Liu SL, Qi MH, Zou X, Wu J, Zhang J. Herbal medicine Guan Chang Fu Fang enhances 5-fluorouracil cytotoxicity and affects drug-associated genes in human colorectal carcinoma cells. Oncology letters. 2015 Feb;9(2):701-8. PubMed PMID: 25621039. Pubmed Central PMCID: 4301488.
30. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of cell science. 2009 Feb 15;122(Pt 4):437-41. PubMed PMID: 19193868. Pubmed Central PMCID: 2714431.
31. Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, et al. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In vivo. 2007 Jan-Feb;21(1):123-32. PubMed PMID: 17354625.
32. Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Dec 15;13(24):7254-63. PubMed PMID: 18094405.
33. Budram-Mahadeo V, Morris PJ, Latchman DS. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1). Oncogene. 2002 Sep 5;21(39):6123-31. PubMed PMID: 12203124.